Ripple adds digital asset support to treasury management platform
Ripple has added digital asset capabilities to its treasury management platform, allowing corporate finance teams to hold, track and manage cryptocurrencies and fiat balances within a single system, the company said.
According to a company announcement, the update introduces Digital Asset Accounts and a unified dashboard that aggregates balances across bank accounts, custody providers and onchain wallets, giving treasury teams real-time visibility into both cash and digital assets.
The system supports assets including XRP (XRP) and Ripple USD (RLUSD), with balances updated in real time and recorded alongside fiat transactions. APIs connect external custodians and sync activity into the platform, according to Ripple.
Ripple said the update embeds digital asset functionality directly into its treasury system, rather than requiring separate crypto platforms. The company said this could reduce reliance on manual reconciliation and fragmented reporting across banking and custody systems.
The launch follows Ripple’s October acquisition of GTreasury for $1 billion. The company said the product is already live for customers in beta ahead of a broader rollout, with availability varying by jurisdiction depending on regulatory requirements and geography.
Related: Ripple CEO says stablecoins could be crypto’s ‘ChatGPT moment’ for businesses
Digital assets move into financial infrastructure
A survey published by Ripple in March found that 72% of more than 1,000 global finance leaders believe companies must offer digital asset solutions to remain competitive, reflecting growing focus on custody, security and infrastructure.
The findings point to a broader shift from adoption to integration, as institutions look to incorporate these assets into existing financial systems rather than manage them separately.
That transition is driving increased activity across financial infrastructure. In July, Visa expanded its settlement platform to support additional stablecoins and blockchain networks, building on its initial use of USDC (USDC) for settlement in 2021.
Banks have also begun integrating tokenized money into their operations. In November, JPMorgan expanded access to its JPM Coin deposit token, allowing institutional clients to move funds on blockchain networks for real-time settlement.
Similar efforts are emerging in credit and capital markets. In October, Securitize and BNY Mellon said they would collaborate to bring instruments such as collateralized loan obligations onchain.
Magazine: XRP yet to ‘price in’ 3 bullish catalysts, Bitcoin to $80K? Trade Secrets
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
